Cas:887589-87-9 2-piperazine-tert-butyl-carboxamide manufacturer & supplier

Chemical Name:2-piperazine-tert-butyl-carboxamide

CAS.NO:887589-87-9

Synonyms:2-piperazine-tert-butyl-carboxamide

Molecular Formula:C₉H₁₉N₃O

Molecular Weight:185.26700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:67.15000

Exact Mass:185.15300

LogP:0.80730

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-piperazine-tert-butyl-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-piperazine-tert-butyl-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-piperazine-tert-butyl-carboxamide Use and application,2-piperazine-tert-butyl-carboxamide technical grade,usp/ep/jp grade.

Related News: Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. 2-piperazine-tert-butyl-carboxamide manufacturer Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. 2-piperazine-tert-butyl-carboxamide supplier The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 2-piperazine-tert-butyl-carboxamide vendor The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported. 2-piperazine-tert-butyl-carboxamide factory The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement.